Cargando…

Risk of SARS-CoV2 by vaccination status and population characteristics in Qatar

Detalles Bibliográficos
Autores principales:	Syed, Mohamed Ahmed, Al Nuaimi, Ahmed Sameer, A/Qotba, Hamda Abdulla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of British Infection Association. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095073/ https://www.ncbi.nlm.nih.gov/pubmed/35578659 http://dx.doi.org/10.1016/j.clinpr.2022.100148

Ejemplares similares

Prevalence of metabolic syndrome in primary health settings in Qatar: a cross sectional study
por: Syed, Mohamed Ahmed, et al.
Publicado: (2020)

Antibody Response to SARS-CoV-2: A Cohort Study in Qatar’s Primary Care Settings
por: Syed, Mohamed Ahmed, et al.
Publicado: (2021)

SARS-CoV-2 seropositivity and subsequent infection risk: a prospective cohort study
por: Syed, Dr. Mohamed Ahmed, et al.
Publicado: (2022)

Vitamin D status among adults (18–65 years old) attending primary healthcare centres in Qatar: a cross-sectional analysis of the Electronic Medical Records for the year 2017
por: Zainel, Abdul-Jaleel A Latif, et al.
Publicado: (2019)

Rates of recurrent positive SARS-CoV-2 swab results among patients attending primary care in Qatar
por: Hamed, Ehab, et al.
Publicado: (2021)

Epidemiology of SARS-CoV2 in Qatar’s primary care population aged 10 years and above
por: Syed, Mohamed Ahmed, et al.
Publicado: (2021)

COVID-19 Surveillance in the Primary Health Care Population of Qatar: Experience of Prioritizing Timeliness Over Representativeness When Sampling the Population
por: A/Qotba, Hamda Abdulla, et al.
Publicado: (2021)

Development of a model to deliver primary health care in Qatar
por: Syed, Mohamed Ahmed, et al.
Publicado: (2020)

Estimating point prevalence of COVID-19 in Qatar’s primary care registered population: an RT-PCR drive-through study protocol
por: Syed, Mohamed Ahmed, et al.
Publicado: (2021)

Clinical characteristics of 51,815 patients presenting with positive and negative SARS-CoV-2 swab results in primary health care settings: Priority populations for vaccination
por: Hamed, Ehab, et al.
Publicado: (2021)

Effectiveness of COVID-19 vaccines
por: Syed, Mohamed Ahmed, et al.
Publicado: (2022)

Diabetes, hypertension and dyslipidemia medication prescribing in Qatari primary care settings: a retrospective analysis of electronic medical records
por: Syed, Mohamed Ahmed, et al.
Publicado: (2021)

Prevalence of non-communicable diseases by age, gender and nationality in publicly funded primary care settings in Qatar
por: Syed, Mohamed A, et al.
Publicado: (2019)

Predictive Ability of Factors in diagnosing COVID-19: Experiences from Qatar's Primary Care Settings
por: Syed, Dr. Mohamed Ahmed, et al.
Publicado: (2022)

Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
por: Abu-Raddad, Laith J., et al.
Publicado: (2021)

Children and adolescents coping with home isolation and social distancing during Covid-19 in Qatar: a cross sectional study with qualitative items
por: Zainel, Abduljaleel Abdullatif, et al.
Publicado: (2023)

SARS-CoV-2 re-infection: a case report from Qatar
por: AlFehaidi, Alanoud, et al.
Publicado: (2021)

Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
por: Abu-Raddad, Laith J., et al.
Publicado: (2022)

Haematological abnormalities and risk of COVID-19 infection in adult patients attending primary healthcare settings
por: Hamed, Ehab, et al.
Publicado: (2020)

Drivers of MERS-CoV Emergence in Qatar
por: Farag, Elmoubasher, et al.
Publicado: (2018)

Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar
por: Tayar, Elias, et al.
Publicado: (2023)

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
por: Chemaitelly, Hiam, et al.
Publicado: (2021)

SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar
por: Al-Thani, Mohamed H, et al.
Publicado: (2021)

Assessment of Indoor Air Quality of Four Primary Health Care Centers in Qatar
por: Abdelrahman, Hana, et al.
Publicado: (2022)

SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar
por: Seedat, Shaheen, et al.
Publicado: (2021)

Drivers for MERS-CoV emergence in Qatar
por: Farag, E., et al.
Publicado: (2016)

Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar
por: Butt, Adeel A., et al.
Publicado: (2023)

One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar
por: Benslimane, Fatiha M., et al.
Publicado: (2021)

Qatar Medical Journal at the forefront of medical publishing
por: Al-Nuaimi, Saffiyah
Publicado: (2016)

SARS-CoV-2 vaccination and uveitis: Are they linked?
por: Waseem, Summaiyya, et al.
Publicado: (2022)

The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2
por: Alluwaimi, Ahmed M., et al.
Publicado: (2020)

Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar
por: Abu-Raddad, Laith J., et al.
Publicado: (2022)

Occupational Exposure to Dromedaries and Risk for MERS-CoV Infection, Qatar, 2013–2014
por: Reusken, Chantal B.E.M., et al.
Publicado: (2015)

SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals
por: Coyle, Peter V., et al.
Publicado: (2021)

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
por: Ahmed, Syed Faraz, et al.
Publicado: (2020)

Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies
por: Zedan, Hadeel T., et al.
Publicado: (2022)

Performance evaluation of novel fluorescent-based lateral flow immunoassay (LFIA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals
por: Shurrab, Farah M., et al.
Publicado: (2022)

Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19
por: Ayoub, Houssein H, et al.
Publicado: (2021)

Low Risk of Serological Cross-Reactivity between the Dengue Virus and SARS-CoV-2-IgG Antibodies Using Advanced Detection Assays
por: Shurrab, Farah M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cg3grab5kg45blipu9b04h4ou3